BenchSci

About

BenchSci uses AI to empower scientists to run more successful experiments to accelerate drug discovery.

Toronto,Ontario,Canada
101 - 250
https://www.benchsci.com/

Highlights

Details

Last Funding Type: Series C
Last Funding Money Raised: $63M
Industries: Artificial Intelligence,Biotechnology,Life Science,Machine Learning,Pharmaceutical
Founded date: Jan 1, 2015
Number Of Employee: 101 - 250
Operating Status: Active
Legal Name: BenchSci

BenchSci uses AI to empower scientists to run more successful experiments to accelerate drug discovery.

BenchSci's vision is to bring medicine to patients 50% faster by 2025.

The company empowers scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments. Backed by F-Prime, Gradient Ventures (Google’s AI fund), and Inovia Capital, BenchSci's proprietary technology accelerates science at 15 top 20 pharmaceutical companies and over 4,300 leading research centers worldwide. BenchSci is a CIX Top 10 Growth company, certified Great Place to Work, and top-ranked company on Glassdoor.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

9

$82.63M $29.50M

BenchSci has raised a total of $82.63M $29.50M in funding over 2 rounds. Their latest funding was raised on Jan 24, 2022 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jan 24, 2022	Series C	$63M	2	Inovia Capital TCV	—	Detail
Feb 4, 2020	Debt Financing	$7.50M	—	—	—	Detail
Feb 4, 2020	Series B	$22M	6	F-Prime Capital	—	Detail
Jun 26, 2019	Series A	$6.68M	1	Gradient Ventures	—	Detail
May 2, 2018	Series A	$10.20M	7	Inovia Capital	—	Detail

Investors

Number of Lead Investors

Number of Investors

7

14

BenchSci is funded by 14 investors. Inovia Capital and TCV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Inovia Capital	Yes	Series C
TCV	Yes	Series C
F-Prime Capital	Yes	Series B
Golden Ventures	—	Series B
Gradient Ventures	—	Series B
Northleaf Capital Partners	—	Series B
Real Ventures	—	Series B
500 Startups Canada	—	Series A
Afore Capital	—	Series A
Radical Ventures	—	Series A